Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
1.830
+0.010 (0.55%)
Nov 4, 2024, 4:00 PM EST - Market closed
Immutep Employees
Immutep had 31 employees as of June 30, 2014.
Employees
31
Change
n/a
Growth
n/a
Revenue / Employee
$82,687
Profits / Employee
-$919,373
Market Cap
268.64M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2014 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AngioDynamics | 748 |
| Sight Sciences | 214 |
| AVITA Medical | 207 |
| Vanda Pharmaceuticals | 203 |
| TScan Therapeutics | 154 |
| Heron Therapeutics | 126 |
| Lexeo Therapeutics | 58 |
| Sera Prognostics | 57 |
IMMP News
- 6 days ago - Immutep Quarterly Activities Report Q1 FY25 - GlobeNewsWire
- 25 days ago - Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 4 weeks ago - Immutep: Navigating The Bumps In The Road - Seeking Alpha
- 7 weeks ago - Immutep's Efti in Combination with MSD's KEYTRUDA® Leads to Positive Efficacy with Favourable Safety in First Line Head and Neck Cancer - GlobeNewsWire
- 3 months ago - Immutep Quarterly Activities Report Q4 FY24 - GlobeNewsWire
- 4 months ago - Immutep: Positive Efti Treatment Data Leads To Late-Stage Programs - Seeking Alpha
- 4 months ago - Immutep Reports Positive Results in First Line Head and Neck Squamous Cell Carcinoma Patients with Negative PD-L1 Expression - GlobeNewsWire
- 4 months ago - Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical Results - GlobeNewsWire